Lutein
(Synonyms: 叶黄素) 目录号 : GC44093
Lutein是一种天然存在的类胡萝卜素,具有多种生物活性,广泛存在于绿叶蔬菜、玉米和蛋黄中。
Cas No.:127-40-2
Sample solution is provided at 25 µL, 10mM.
Lutein is a naturally occurring carotenoid with multiple biological activities and is widely found in green leafy vegetables, corn, and egg yolks[1]. Lutein is the main pigment component of the macula of the human retina and has strong antioxidant and blue light filtering properties[2]. As an important dietary nutrient, Lutein can play a positive role in visual health and neuroprotection by reducing oxidative stress and inflammatory responses[3].
In vitro, Lutein (0.5-2.0μM) treatment of human breast cancer cell lines (MCF-7 and MDA-MB-468 cells) for 48h inhibited the growth of breast cancer cells, but had no effect on normal breast epithelial cells, induced breast cancer cell cycle arrest, and significantly increased the level of ROS in breast cancer cells[4]. Lutein (1μM) pretreatment of ARPE-19 cells for 12h protected the cells from tert-butyl peroxide (tBHP)-induced oxidative stress and cell death[5]. Pretreatment of peripheral blood mononuclear cells (PBMCs) from patients with stable angina (SA) with Lutein (1, 5, 25μM) for 24h reduced LPS-induced secretion of IL-6, IL-1β, and TNF, and decreased the expression of IL-6, IL-1β, and TNF mRNA in a dose-dependent manner[6].
In vivo, Lutein (0.2mg/kg) was administered intraventricularly to treat ischemic stroke model mice, which improved the survival rate and neurological function score of the mice, reduced the infarct area and volume, and reduced the immunoreactivity of nitric oxide tyrosine, poly ADP ribose, and NFκB in brain tissue. It also reduced the levels of Cox-2, pERK, and pIκB in brain tissue, and increased the levels of Bcl-2, heat shock protein 70, and pAkt[7].
References:
[1] Fuad N I N, Sekar M, Gan S H, et al. Lutein: A comprehensive review on its chemical, biological activities and therapeutic potentials[J]. 2020.
[2] Kijlstra A, Tian Y, Kelly E R, et al. Lutein: more than just a filter for blue light[J]. Progress in retinal and eye research, 2012, 31(4): 303-315.
[3] Mrowicka M, Mrowicki J, Kucharska E, et al. Lutein and zeaxanthin and their roles in age-related macular degeneration—neurodegenerative disease[J]. Nutrients, 2022, 14(4): 827.
[4] Gong X, Smith J R, Swanson H M, et al. Carotenoid lutein selectively inhibits breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms[J]. Molecules, 2018, 23(4): 905.
[5] Gong X, Draper C S, Allison G S, et al. Effects of the macular carotenoid lutein in human retinal pigment epithelial cells[J]. Antioxidants, 2017, 6(4): 100.
[6] Chung R W S, Leanderson P, Lundberg A K, et al. Lutein exerts anti-inflammatory effects in patients with coronary artery disease[J]. Atherosclerosis, 2017, 262: 87-93.
[7] Li S Y, Yang D, Fu Z J, et al. Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke[J]. Neurobiology of disease, 2012, 45(1): 624-632.
Lutein是一种天然存在的类胡萝卜素,具有多种生物活性,广泛存在于绿叶蔬菜、玉米和蛋黄中[1]。Lutein是人眼视网膜黄斑区的主要色素成分,具有强大的抗氧化和蓝光过滤特性[2]。Lutein作为一种重要的膳食营养素,能够通过减少氧化应激和炎症反应,对视觉健康和神经保护起到积极作用[3]。
在体外,Lutein(0.5-2.0μM)处理人类乳腺癌细胞系(MCF-7和MDA-MB-468细胞)48h,抑制了乳腺癌细胞生长,但对正常乳腺上皮细胞无影响,诱导了乳腺癌细胞周期阻滞,显著增加了乳腺癌细胞内ROS水平[4]。Lutein(1μM)预处理ARPE-19细胞12h,保护了细胞免受叔丁基过氧化物(tBHP)诱导的氧化应激和细胞死亡[5]。Lutein(1、5、25μM)预处理稳定型心绞痛(SA)患者的外周血单核细胞(PBMCs)24h,以剂量依赖性降低了LPS诱导的IL-6、IL-1β和TNF的分泌,降低了IL-6、IL-1β和TNF mRNA的表达[6]。
在体内,Lutein(0.2mg/kg)通过脑室内注射治疗缺血性卒中模型小鼠,提高了小鼠的存活率和神经功能评分,减小了梗死面积和体积,降低了脑组织中一氧化氮酪氨酸、聚ADP核糖和NFκB的免疫反应性, 降低了脑组织中Cox-2、pERK和pIκB水平,升高了Bcl-2、热休克蛋白70和pAkt水平[7]。
| Cell experiment [1]: | |
Cell lines | Primary mammary epithelial cells (PmECs)、MCF-7 cells、MDA-MB-468 cells |
Preparation Method | Cells were grown in 96-well plates and treated with Lutein (0.5-2.0μM) or DMSO for 48h. Cell viability was measured by MTT assay. |
Reaction Conditions | 0.5-2.0μM; 48h |
Applications | Lutein treatment inhibits cell growth in human breast cancer cells but not in normal mammary epithelial cells. |
| Animal experiment [2]: | |
Animal models | C57BL/6N male mice |
Preparation Method | Two-hour cerebral ischemia was induced by unilateral middle cerebral artery occlusion (MCAo) in mice. Either Lutein (0.2mg/kg) or vehicle was given to mice intraperitoneally 1 h after MCAo and 1 h after reperfusion. Neurological deficits were evaluated at 22h after reperfusion while survival rate was assessed daily until 7 days after reperfusion. Brains were cut into 2 mm-thick coronal slices and stained with 2% 2,3,5-triphenyltetrazolium chloride to determine the infarct size after MCAo. Paraffin-embedded brain sections were prepared for TUNEL assay and immunohistochemistry. Protein lysate was collected for Western blotting experiments. |
Dosage form | 0.2mg/kg; i.c.v. |
Applications | Higher survival rate, better neurological scores, smaller infarct area and smaller infarct volume were noted in the Lutein-treated group. Immunohistochemistry data showed a decrease of immunoreactivity of nitrotyrosine, poly (ADP-ribose) and NFκB in the Lutein-treated brains. Western blotting data showed decreased levels of Cox-2, pERK, and pIκB, but increased levels of Bcl-2, heat shock protein 70 and pAkt in the Lutein-treated brains. |
References: | |
| Cas No. | 127-40-2 | SDF | |
| 别名 | 叶黄素 | ||
| Canonical SMILES | O[C@@H]1CC(C)(C)[C@@H](/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C)C)C(C)=C1 | ||
| 分子式 | C40H56O2 | 分子量 | 568.9 |
| 溶解度 | Chloroform: 5 mg/ml,DMF: 10 mg/ml,DMF:PBS (pH 7.2) (1:1): 0.5 mg/ml,DMSO: 5 mg/ml | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.7578 mL | 8.7889 mL | 17.5778 mL |
| 5 mM | 351.6 μL | 1.7578 mL | 3.5156 mL |
| 10 mM | 175.8 μL | 878.9 μL | 1.7578 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















